A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Actinic Keratosis (AK)
In brief
Once or twice daily 12 week treatment in patients with Actinic Keratosis randomized to treatment in one of four arms.
Key facts
- Study ID
- NCT03116698
- Run by
- Dr. Reddy's Laboratories Limited
- People needed
- 240
- Starts
- 2017-02-14
- Expected to finish
- 2018-07-05
- Last updated by the study team
- 2019-04-24
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Investigator Site 3 — Cerritos, California, United States
- Investigator Site 1 — Fremont, California, United States
- Investigator Site 9 — Palm Springs, California, United States
- Investigator Site 18 — Santa Ana, California, United States
- Investigator Site 16 — Boca Raton, Florida, United States
- Investigator Site 8 — Lake City, Florida, United States
- Investigator Site 7 — Miami, Florida, United States
- Investigator Site 19 — Miami, Florida, United States
- Investigator Site 20 — Miami Lakes, Florida, United States
- Investigator Site 17 — Ormond Beach, Florida, United States
- Investigator Site 6 — West Palm Beach, Florida, United States
- Investigator Site 13 — Verona, New Jersey, United States
- Investigator Site 15 — Stony Brook, New York, United States
- Investigator Site 14 — Fort Washington, Pennsylvania, United States
- Investigator Site 10 — Austin, Texas, United States
- Investigator Site 4 — Houston, Texas, United States
- Investigator Site 5 — Plano, Texas, United States
- Investigator Site 11 — San Antonio, Texas, United States
- Investigator Site 2 — San Antonio, Texas, United States
- Investigator Site 12 — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.